CLEARMIND MEDICINE, INC

Lobbying client · British Columbia · filed 2025 to 2026

Developer of Psychedelics Medicines

$60,000 Reported spend

6 Filings counted

1 Firms hired

6 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (67871), not by name.

Firms hired 1

RK STRATEGIES, INC. $60,000 6 filings

Bills named in these filings 6

HR 2623
Innovative Therapies Centers of Excellence Act of 2025

4 filings
HR 7091
Expanding Veterans’ Access to Emerging Treatments Act

3 filings
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…

2 filings
HR 8800
National Defense Authorization Act for Fiscal Year 2027

1 filing
HR 9237
Take Care of America’s Veterans Act

1 filing
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

1 filing

Reported by year 2 years

2026 $30,000 2 filings
2025 $30,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Health & Human Services, Dept of (HHS) 5
HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

Q2

RK STRATEGIES, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 18, 2026

View → Q1

RK STRATEGIES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 20, 2026

View → Q4

RK STRATEGIES, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $10,000 income · posted Jan 20, 2026

View → Q3

RK STRATEGIES, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $10,000 income · posted Oct 20, 2025

View → Q2

RK STRATEGIES, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 21, 2025

View → RR

RK STRATEGIES, INC.

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 16, 2025

View →

Foreign entities disclosed 1

CLEARMIND MEDICINE, INC. Israel named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $10,000

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.